Limitations were common to studies based on claim databases and included the use of algorithms to record incident PCa and define stage at diagnosis, the lack of information on PSA test indication (sometimes unrelated to PCa screening6), and PSA results. Here, KLK3 is linked to posterior cortical atrophy.